Found: 3
Select item for more details and to access through your institution.
Survivin (BIRC5) Peptide Vaccine in the 4T1 Murine Mammary Tumor Model: A Potential Neoadjuvant T Cell Immunotherapy for Triple Negative Breast Cancer: A Preliminary Study.
- Published in:
- Vaccines, 2023, v. 11, n. 3, p. 644, doi. 10.3390/vaccines11030644
- By:
- Publication type:
- Article
Survivin Expression in Luminal Breast Cancer and Adjacent Normal Tissue for Immuno-Oncology Applications.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 14, p. 11827, doi. 10.3390/ijms241411827
- By:
- Publication type:
- Article
Analysis of well-annotated next-generation sequencing data reveals increasing cases of SARS-CoV-2 reinfection with Omicron.
- Published in:
- Communications Biology, 2023, v. 6, n. 1, p. 1, doi. 10.1038/s42003-023-04687-4
- By:
- Publication type:
- Article